On the fifth annual Most Fundable Companies® List published by the Pepperdine Graziadio Management
School; Bridge Therapeutics won against a field of more than 4,000 other early-stage American startups.
The Most Fundable Businesses project aims to inform founders about the investor due diligence process and honor extraordinary business people who are coming up with creative solutions to today’s problems while also looking for investment cash to support their company’s expansion.
Tim Peara, president of Bridge, said, “As a 4-year-old start-up with high ambitions, being named a Most
Fundable Company of 2022 positions us well for our next capital round and gets us one step closer to
establishing market leadership.
“We’re happy to have won through data-driven research in The Most Fundable Businesses initiative, which was one of the most rigorous scrutiny processes we’ve ever taken part in.
We are thrilled that the Pepperdine Graziadio Business School is providing entrepreneurs with a forum to showcase their businesses and position them for success with investors because entrepreneurial company innovation is the lifeblood of the US economy.
Bridge is creating safe and effective alternatives to opioid painkillers as well as significant advancements in
addiction treatment. Bridge is a very low-risk business because it combines tried-and-true components with the greatest delivery system available, targets markets worth billions of dollars, and increases entry barriers with each new medicine.
About Pepperdine Most Fundable Businesses
The Pepperdine Graziadio Management School’s yearly initiative, The Most Fundable Businesses List, aims to encourage the spirit of entrepreneurship across the country by providing avenues for startup finance.
For the 2022 program, more over 4,000 businesses from all 50 states submitted applications. On October 13, 2022, at Pepperdine University’s Villa Grazio Executive Center, the Pepperdine Graziadio Business School’s Most Fundable Businesses Showcase presented by the Singleton Foundation for Financial Literacy and Entrepreneurship took place.
The Pepperdine Graziadio Management School introduced The Most Fundable Businesses initiative in 2018 as a free tool to assist entrepreneurs in determining their suitability for private investment. In order to increase preparation for investment, the program entails a multi-phase assessment that assesses a number of company aspects, including financial predictions, market opportunity, intellectual property, and the management team’s strength. The Venture Alliance is the organization behind Pepperdine Graziadio Business School’s Most Fundable Startups.
Bridge Therapeutics information
A pharmaceutical company in the development stage, Bridge Therapeutics, Inc. (Addiction & Pain Therapies |
Bridge Therapeutics), is working to get the FDA to approve BT-219 for the treatment of opioid use disorder
(OUD) and BT-205 for the management of chronic pain in patients who have used opioids previously. By safer
and more efficient treatments for OUD and chronic pain, the company aims to enhance the healthcare of
millions of people.
To contact Bridge for a prospectus
